Predicting the dynamics of heart rate variability in patients with type 1 diabetes against improving glycemic control

Авторы

DOI:

https://doi.org/10.26641/2307-0404.2024.2.307585

Ключевые слова:

type I diabetes, heart rate variability, glucose control, vago-sympathetic balance

Аннотация

The aim of the study: to analyze the effect of improvement of glycemic control on heart rate variability changes in patients with type 1 diabetes against the background of insulin therapy correction and to predict this dynamics based on the parameters of continuous glucose monitoring. We examined 49 patients with the level of glycosylated hemoglobin ≥7% and <10% without late diabetic complications. The average age – 32.0 (21.5; 38.0) years, the average disease duration – 9.5 (5.0; 17.5) years. The study was based on the simultaneous registration of heart rate variability and continuous glucose monitoring before and 3 months after correction of insulin therapy. Logistic regression analysis and ROC-analysis were used to predict the changes. After 3 months, the patients had significant decrease in the level of glycosylated hemoglobin, glycose variability, and a decrease in the frequency of hypoglycemic episodes. Heart rate variability increased in 73.5% of persons. The presence of hypoglycemia, standard deviation of blood glucose levels and glomerular filtration rate after treatment turned out to be prognostic factors for the predicting improvement in heart rate variability (the proportion of correct prediction of the patient's actual belonging to one or another prognostic group was 76.39%). Based on the calculation of the theoretical values of the positive result probability using the logistic equation, a detailed scale for predicting changes in heart rhythm variability for type 1 diabetes patients was proposed: up to 0.07 – a low probability of a positive result; 0.07-0.29 – the probability of a positive result is below average; 0.29-0.51 – a moderate probability of a positive result; 0.51-0.90 – high probability of a positive result; more than 0.90 – a very high probability of a positive result. We found that improvement of glycemic control leads to an increase in both frequency and time characteristics of heart rate variability. The increase in the likelihood of improvement of heart rate variability in patients with type 1 diabetes was more likely to be associated with reduced glycose variability and fewer hypoglycemic episodes. We developed a predictive mathematical model of heart rate variability based on the continuous glucose monitoring parameters for type 1 diabetes with sensitivity of 88.0% and specificity 68.18%, AUC 0.739 (p=0.001).

Библиографические ссылки

Deka B, Deka D. Nonlinear analysis of heart rate variability signals in meditative state: a review and perspective. Biomed Eng Online. 2023;22(1):35. doi: https://doi.org/10.1186/s12938-023-01100-3

Siepmann M, Weidner K, Petrowski K, Siepmann T. Heart rate variability: a measure of cardiovascular health and possible therapeutic target in dysautonomic mental and neurological disorders. Appl psychophysiol biofeedback. 2022;47(4):273-87. doi: https://doi.org/10.1007/s10484-022-09572-0

Shkala LV. [Heart damage in diabetes]. Simeina medytsyna. 2022;1-2:81-4. Ukrainian. doi: https://doi.org/10.30841/2307-5112.1-2.2022.260509

Hajdu M, Garmpis K, Vértes V, Vorobcsuk-Varga N, Molnár GA, Hejjel L, et al. Determinants of the heart rate variability in type 1 diabetes mellitus. Front Endocri¬nol (Lausanne). 2023;14:1247054. doi: https://doi.org/10.3389/fendo.2023.1247054

Duque A, Mediano MFF, De Lorenzo A, Rodrigues LF. Cardiovascular autonomic neuropathy in dia-betes: Pathophysiology, clinical assessment and im-plications. World J Diabetes. 2021;12(6):855-67. doi: https://doi.org/10.4239/wjd.v12.i6.855

Zhou Z, Sun B, Huang S, Zhu C, Bian M. Gly-cemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol. 2020;19(1):102. doi: https://doi.org/10.1186/s12933-020-01085-6

American Diabetes Association. Standards of Medical Care in Diabetes – 2023 [Internet]. Diabetes Care. 2023 [cited 2024 Jan12];46(Suppl 1). Available from: https://diabetesjournals.org/care/issue/46/Supplement_1

[The unified clinical protocols of primary, emergency and specialized medical care. Type 1 diabetes in adults. Order of HM Ukraine from 2023 Jan 26 N 151]. [Internet]. Kyiv; 2023 [cited 2024 Jan 12]. Ukrainian. Available from: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-26012023--151-pro-zatverdzhennja-unifikovanogo-klinichnogo-protokolu-pervinnoi-ekstrenoi-ta-specializovanoi-medichnoi-dopomogi-cukrovij-diabet-1-tipu-u-doroslih

9.Chouhan AS, Kaple M, Hingway S. A Brief Review of Diagnostic Techniques and Clinical Management in Chronic Kidney Disease. Cureus [Internet]. 2023Nov.18;. Available from: https://www.cureus.com/articles/196508-a-brief-review-of-diagnostic-techniques-and-clinical-management-in-chronic-kidney-disease

Tiwari R, Kumar R, Malik S, Raj T, Kumar P. Analysis of heart rate variability and implication of different factors on heart rate variability. Curr Cardiol Rev. 2021;17(5):e160721189770. doi: https://doi.org/10.2174/1573403X16999201231203854

Lisun YuB, Uglev YeІ. [Heart rate variability, use and methods of analysis]. Pain, anaesthesia & intensive care. 2020;4(93):83-9. Ukrainian. doi: https://doi.org/10.25284/2519-2078.4(93).2020.220693

Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-625. doi: https://doi.org/10.2337/dci21-0043

Hruzieva TC, Liehan VM, Ogniev VA, Нaliienko LI, Kriachkova LV, Palamar BI, et al. [Biostatistics]. Vinnytsia: Nova knyha; 2020. 384 p. Ukrainian.

Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25-36. doi: https://doi.org/10.4097/kja.21209

Schober P, Vetter TR. Logistic Regression in Medical Research. Anesth Analg. 2021;132(2):365-6. doi: https://doi.org/10.1213/ANE.0000000000005247

Spallone V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet. Diabetes Metab J. 2019;43(1):3‐30. doi: https://doi.org/10.4093/dmj.2018.0259

18.Sztanek F, Jebelovszki Éva, Gaszner B, Zrínyi M, Páll D, Kempler P, Harangi M. A diabeteses cardialis autonóm neuropathia diagnosztikája. Orvosi Hetilap [Internet]. 2019Sep.1;160(35):1366-75. Available from: https://www.akademiai.com/doi/10.1556/650.2019.31491

Jayachandra S, Kodidala SR. A study of heart rate variability in diabetic mellitus patients. International journal of endocrinology (Ukraine). 2022;18(3):153-6. doi: https://doi.org/10.22141/2224-0721.18.3.2022.1162

Опубликован

2024-06-28

Как цитировать

1.
Pertseva N, Moshenets K. Predicting the dynamics of heart rate variability in patients with type 1 diabetes against improving glycemic control. Med. perspekt. [Интернет]. 28 июнь 2024 г. [цитируется по 17 июль 2024 г.];29(2):87-94. доступно на: https://journals.uran.ua/index.php/2307-0404/article/view/307585

Выпуск

Раздел

CLINICAL MEDICINE